Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Prevalence of Financial Burden and Impact of Cancer on Financial toxicIty in Patients With Early-stage Breast Cancer

NCT07354165 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.

NCT NCT07354165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07354165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Prevalence of Financial Burden and Impact of Cancer on Financial toxicIty in Patients With Early-stage Breast Cancer
Lead sponsor
National Cancer Institute, Naples
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2025
Completion date
September 30, 2034
Enrollment
864 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer